Aimagine Care Technology Co., Ltd.

Founded in 2018, the company is an AI medical platform based on large model technology, focusing on microscopic morphological analysis and other experimental diagnostics. The company's first product is an AI driven peripheral blood cell morphological analyzer, which has obtained the FIRST market license of class III medical device in the IVD field in China with CE license certified.